马辅助干预和阿尔茨海默病:一个非随机的,受控的多中心研究
1University of Tours, Tours, France.
概括
马辅助干预 (EAI) 在阿尔茨海默病 (AD) 的老年人中显著改善了心理健康. EAI减少了行为问题和抑郁症状,提高了生活质量.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
背景情况:
- 阿尔茨海默病 (AD) 对老年人构成重大挑战,需要有效的非药物干预措施.
- 现有的护理模式往往没有足够的重点关注阿兹海默症患者的心理健康和环境丰富.
研究的目的:
- 评估马匹辅助干预 (EAI) 对被诊断患有阿尔茨海默氏病 (AD) 的老年人的心理益处.
- 为了比较EAI与适应体力活动 (APA) 和对照组 (CG) 对心理健康结果的影响.
主要方法:
- 这是一项多中心的非随机对照研究,涉及14个养老院的74名阿尔茨海默氏症老年人.
- 参与者被分配到EAI计划,适应体力活动计划 (APA) 或对照组 (CG).
- 心理健康,包括心理行为障碍,生活质量和抑郁症状,在六周后进行评估.
主要成果:
- EAI组在第六周显示精神行为障碍的减少.
- EAI组的参与者报告生活质量有所改善,抑郁症状略有减少.
- 在适应体力活动 (APA) 或对照组 (CG) 中没有观察到显著的心理益处.
结论:
- 马辅助干预 (EAI) 显示出作为一种补充性,非药物治疗方法来管理阿尔茨海默病 (AD) 的承诺.
- 埃艾有助于环境的丰富,积极影响的情感福祉,生活质量和舒适的个人与AD在机构设置.
相关概念视频
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Alzheimer's Disease: Overview
686
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686


